Millennium Management’s OncoSec Medical Incorporated ONCS Stock Holding History

Millennium Management’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,364	Closed	-$84K	–	7661
2021 Q2	$84K	Sell	1,364 -6,425	-82%	-$583K	﹤0.01%	6276
2021 Q1	$817K	Buy	7,789 +5,052	+185%	+$691K	﹤0.01%	4401
2020 Q4	$388K	Buy	2,737 +1,993	+268%	+$213K	﹤0.01%	4393
2020 Q3	$55	Buy	+744	New	+$58K	﹤0.01%	4290
2019 Q1	–	Sell	-182	Closed	-$26K	–	4519
2018 Q4	$26K	Sell	182 -137	-43%	-$34.4K	﹤0.01%	3658
2018 Q3	$98K	Sell	319 -5,114	-94%	-$1.57M	﹤0.01%	3738
2018 Q2	$1.65M	Buy	5,433 +885	+19%	+$310K	﹤0.01%	2520
2018 Q1	$1.88M	Buy	4,548 +4,339	+2,076%	+$1.78M	﹤0.01%	2351
2017 Q4	$75K	Buy	+209	New	+$73.2K	﹤0.01%	3696
2017 Q3	–	Sell	-1,065	Closed	-$279K	–	4082
2017 Q2	$279K	Buy	1,065 +999	+1,514%	+$245K	﹤0.01%	3069
2017 Q1	$19K	Buy	+66	New	+$19.2K	﹤0.01%	3428

Other funds holding ONCS

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Salzhauer Michael $292M AUM 30% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management's ONCS Position: Q3 2021 in Review

Millennium Management sold out of OncoSec Medical Incorporated (ONCS) in Q3 2021, closing a stake of 1,364 shares — an estimated $84K sold.

Millennium Management first reported a position in ONCS in Q1 2017 and held it in 11 quarters. The position peaked at $1.88M in Q1 2018. 31 funds tracked by Wall St. Rank hold ONCS as of Q3 2021.

Millennium Management reported no remaining OncoSec Medical Incorporated position as of Q3 2021 after selling out during the quarter.
Millennium Management sold 1,364 OncoSec Medical Incorporated shares in Q3 2021, an estimated $84K.
Millennium Management first reported a position in OncoSec Medical Incorporated in Q1 2017 and held it in 11 quarters.
Millennium Management's OncoSec Medical Incorporated position peaked at $1.88M in Q1 2018.
31 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q3 2021.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.